Citations Cleveland Clinic on Semaglutide Injection for Weight Management National Institute of Diabetes and Digestive and Kidney Diseases ( for general weight loss information.
In another study, 73 of 77 participants underwent repeat DaTSPECT imaging at 96 weeks, but no significant differences in striatal binding changes were observed between the exenatide and placebo groups across all regions analyzed [34]
Novo Nordisks strong clinical data and successful commercialization of its GLP-1 receptor agonist portfolio have established it as a market leader
More serious but rare adverse events include pancreatitis, gallbladder disease, and thyroid C-cell tumours (patients should be advised to report symptoms such as neck mass, dysphagia or persistent hoarseness)
Muscle helps the body regulate blood sugar, supports strength for everyday tasks, and is a strong predictor of balance and independence as we get older
The majority of insurance plans specifically exclude coverage for weight loss medications, even when prescribed by a physician for obesity management